Skip to content

13F-HR filed by TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 10 holding rows worth $739,969,000.

Accession
0001214659-19-005293
Filed
2019-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2019

A holdings report, 10 entries on the cover page, a total value of $739,969,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $739,969,000 with VALUE read as thousands by filing date, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ODONATE THERAPEUTICS INC676079106COM14,075,269$516,422,000thousands by filing date
HERON THERAPEUTICS INC427746102COM5,744,096$106,783,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 24,938,893$45,685,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM2,965,485$44,482,000thousands by filing date
CELGENE CORP151020104COM111,844$10,339,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM200,000$6,132,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK349,400$4,441,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock323,823$3,423,000thousands by filing date
CELLECTAR BIOSCIENCES INC15117F500COM PAR680,000$1,482,000thousands by filing date
IVERIC BIO INC46583P102COM600,000$780,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-19-005293this filing2019-08-14acceptance time not in the bulk data set